Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 17.61
+0.43 (2.50%)
Sep 25, 2026, 5:30 PM CET
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 698.65 million as of September 25, 2026. Its market cap has decreased by -24.67% in one year.
Market Cap
698.65M
Enterprise Value
683.90M
Revenue
141.35M
Ranking
n/a
PE Ratio
100.81
Stock Price
17.61
ChartMarket Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 3.25B to 698.65M, a decrease of -78.50%. That is a compound annual growth rate of -13.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 698.65M | -35.07% |
| Dec 30, 2025 | 1.08B | 33.56% |
| Dec 30, 2024 | 805.64M | 527.99% |
| Dec 29, 2023 | 128.29M | 138.81% |
| Dec 30, 2022 | 53.72M | -14.90% |
| Dec 30, 2021 | 63.13M | -4.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 288.66B |
| Novartis AG | 227.71B |
| Lonza Group AG | 39.76B |
| Galderma Group AG | 38.01B |
| Aevis Victoria | 1.36B |
| Idorsia | 1.17B |
| Medartis Holding AG | 1.07B |
| Cosmo | 960.95M |